Research
And Grants
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
Submit Grant ApplicationThe Cure Starts Now has funded $25,395,277 (USD) in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 167 grants at over 100 hospitals in 29 countries.

Hunter Medical Research Institute – $200,000
$200,000.00
November 2022
DMG COMBATT 2.0: Diffuse Midline Glioma COMbined Anti-Tumor Targeting 2.0

The Institute of Cancer Research – $501,183
$501,183.00
November 2022
Translating Mechanism to Patient Benefit for ACVR1-Mutant Diffuse Intrinsic Pontine Glioma (DIPG)

Cincinnati Children's Hospital – $50,000
$50,000.00
May 2022
Targeting Histone Lysine Demethylases to Treat Diffuse Intrinsic Pontine Glioma

SIOPe DIPG/DMG Registry – $779,018
$779,018.00
March 2022
Renewal of the European DIPG/DMG Registry

Funding of PBTCF 2022 - $25,000
$25,000.00
January 2022

Massachusetts General Hospital – $50,000
$50,000.00
November 2021
Targeted Protein Degradation for DIPG Therapy

CONNECT2007 - $345,794
$345,794.00
September 2021
Phase I/II Study of Lutathera in Pediatric and Young Adult Patients with Recurrent and/or Progressive High-Grade Central Nervous System (CNS) Tumors and Meningiomas which Express Somatostatin Type 2A Receptors and Demonstrate Uptake on DOTATATE

CONNECT2109A - $705,764
$705,764.00
September 2021
CONNECT2109A: A molecularly-guided phase II study of ribociclib and everolimus in children and young adults with newly diagnosed diffuse intrinsic pontine glioma (DIPG) and high-grade glioma (HGG)

CONNECT Consortium - $278,619
$278,619.00
September 2021
Immuno-Modulation to Treat Poor-Prognosis Pediatric Brain Tumors

Institute of Cancer Research – $113,747
$113,747.00
September 2021
Co-Culture Disruptor Screens to Target Cell-Cell Interactions in DMG

Institute of Cancer Research – $498,716
$498,716.00
September 2021
Translating Mechanism to Patient Benefit for ACVR1-Mutant Diffuse Intrinsic Pontine Glioma (DIPG) - An International Connect Consortium Preclinical / Clinical

Sydney Children’s Hospital – $195,327
$195,327.00
September 2021
Phase I/II Study of Oral DFMO and AMXT1501 for DIPG/DMG

Children’s Hospital of Colorado – $200,000
$200,000.00
September 2021
Multimodality, Combination Treatment Strategy for DIPG/DMG

Children's Cancer Institute – $50,000
$50,000.00
September 2021
Developing Novel Combination Therapies for Diffuse Intrinsic Pontine Glioma

Cincinnati Children's Hospital – $200,000
$200,000.00
September 2021
Targeting Purine Synthesis and One Carbon Metabolism in DIPG